1. Reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19.
- Author
-
Guimarães TC, Marques BBF, Castro MV, Secco DA, Porto LCMS, Tinoco JMM, Tinoco EMB, Fletcher P, and Fischer RG
- Subjects
- Humans, Mouthwashes therapeutic use, Viral Load, Saliva, Chlorhexidine therapeutic use, SARS-CoV-2, COVID-19
- Abstract
Objective: To evaluate the reduction in the salivary viral load using oral antiseptic mouthwashes in patients testing positive for COVID-19., Methods: Sixty-three individuals were recruited after testing positive for COVID-19 by real-time RT-PCR assay and divided into 5 groups. Group 1 received sterile water, group 2 received 1.5% hydrogen peroxide solution (HP), group 3 received 0.12% chlorhexidine (CHX), group 4 received 0.1% sodium hypochlorite solution (NaClO), and group 5 received sequential rinses using CHX and HP. After collecting the initial saliva sample, individuals were asked to use the designated mouthwash for 1 min. Additional saliva samples were collected immediately after rinsing, 15, and 30 min after rinsing. Real-time RT-PCR assays for RNA detection of SARS-CoV-2 were performed on the saliva samples., Results: There were no significant differences among the experimental groups and the control group in any period. Compared to the baseline values, there was a significant reduction in the number of copies of SARS-CoV-2 after 30 min in group 2 and immediately after the initial mouthwash in group 4., Conclusions: No experimental group demonstrated a significant reduction in the viral load compared to the control group., (© 2021 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF